Cargando…

Inhibition of tamoxifen's therapeutic effects by emodin in estrogen receptor-positive breast cancer cell lines

PURPOSE: This study was aimed to investigate the combination effect of endoxifen and emodin on estrogen receptor (ER) positive breast cancer cell lines and to explain the mechanism of the combination effect. METHODS: We conducted this study on MCF-7 (ER+/human epidermal growth factor receptor-2 [HER...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yun Gyoung, Park, Yoon Hwa, Yang, Eun Yoel, Park, Won Seo, Park, Kyoung Sik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848006/ https://www.ncbi.nlm.nih.gov/pubmed/31742207 http://dx.doi.org/10.4174/astr.2019.97.5.230

Ejemplares similares

Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
por: KIM, JINKYOUNG, et al.
Publicado: (2016)

Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line
por: Won, Hye Sung, et al.
Publicado: (2016)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
por: Rangel, Nelson, et al.
Publicado: (2017)

Therapeutic Potential of Emodin for Gastrointestinal Cancers
por: McDonald, Sierra J., et al.
Publicado: (2022)

Inhibition of platelet-derived growth factor receptor synergistically increases the pharmacological effect of tamoxifen in estrogen receptor α positive breast cancer
por: Kim, Sangmin, et al.
Publicado: (2021)

Emodin in Rheum undulatum inhibits oxidative stress in the liver via AMPK with Hippo/Yap signalling pathway
por: Lee, Eun Hye, et al.
Publicado: (2020)

Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice
por: Zhang, Zhi, et al.
Publicado: (2021)

Emodin enhances osteogenesis and inhibits adipogenesis
por: Yang, Feng, et al.
Publicado: (2014)

Partial Inhibition of Estrogen-Induced Mammary Carcinogenesis in Rats by Tamoxifen: Balance between Oxidant Stress and Estrogen Responsiveness
por: Singh, Bhupendra, et al.
Publicado: (2011)

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer
por: Jiang, Cen, et al.
Publicado: (2023)

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
por: Bostner, Josefine, et al.
Publicado: (2017)

Poloxamer-Based Thermoreversible Gel for Topical Delivery of Emodin: Influence of P407 and P188 on Solubility of Emodin and Its Application in Cellular Activity Screening
por: Ban, Eunmi, et al.
Publicado: (2017)

Emodin in cardiovascular disease: The role and therapeutic potential
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ERα Inhibition
por: Huang, Pao-Hsuan, et al.
Publicado: (2013)

Cell Metabolomics Reveals the Potential Mechanism of Aloe Emodin and Emodin Inhibiting Breast Cancer Metastasis
por: Cheng, Guorong, et al.
Publicado: (2022)

Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Emodin
por: Jing, Xubin, et al.
Publicado: (2002)

Berberine Inhibited the Growth of Thyroid Cancer Cell Lines 8505C and TPC1
por: Park, Kyoung Sik, et al.
Publicado: (2012)

miRNAs involved in LY6K and estrogen receptor α contribute to tamoxifen-susceptibility in breast cancer
por: Kim, Ye Sol, et al.
Publicado: (2016)

CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
por: Moon, Yong Wha, et al.
Publicado: (2017)

Emodin coupled with high LET neutron beam—a novel approach to treat on glioblastoma
por: Kim, Jeong-Yub, et al.
Publicado: (2022)

Forced Degradation Studies of Aloe Emodin and Emodin by HPTLC
por: Narayanan, Sindhu, et al.
Publicado: (2015)

The Comparison of the Efficiency of Emodin and Aloe-Emodin in Photodynamic Therapy
por: Nowak-Perlak, Martyna, et al.
Publicado: (2022)

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
por: Loi, Sherene, et al.
Publicado: (2008)

Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
por: Gao, Pin, et al.
Publicado: (2018)

Prognostic significance of autophagy related genes in estrogen receptor positive tamoxifen treated breast cancer
por: Mishra, Alok, et al.
Publicado: (2020)

Role of SALL4 and Nodal in the prognosis and tamoxifen resistance of estrogen receptor-positive breast cancer
por: Boustan, Arad, et al.
Publicado: (2021)

Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors
por: Kim, Hyunsoo, et al.
Publicado: (2023)

HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors
por: Barros, Milton J., et al.
Publicado: (2023)

Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor–Positive Primary Human Breast Tumors
por: Kim, Hyunsoo, et al.
Publicado: (2023)

A Role for Estrogen Receptor Phosphorylation in the Resistance to Tamoxifen
por: de Leeuw, Renée, et al.
Publicado: (2011)

Tamoxifen non-estrogen receptor mediated molecular targets
por: Bogush, Tatiana, et al.
Publicado: (2012)

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
por: Lee, Eun-Shin, et al.
Publicado: (2016)

Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
por: Han, Wonshik, et al.
Publicado: (2006)

Selective inhibition of V600E-mutant BRAF gene induces apoptosis in thyroid carcinoma cell lines
por: Park, Kyoung Sik, et al.
Publicado: (2021)

Promising Role of Emodin as Therapeutics to Against Viral Infections
por: Shao, Qingqing, et al.
Publicado: (2022)

SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells
por: Jin, Ming Li, et al.
Publicado: (2022)

Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2014)

The rate of estrogen receptor‐conversion associated with tumor progression in estrogen receptor‐positive breast cancer patients following adjuvant Tamoxifen administration
por: Djahansouzi, Sirus, et al.
Publicado: (2021)

Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer
por: De Marchi, Tommaso, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2di6bhi8j0eb242vasmtkjr7s0